UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
|
February 28, 2005 | |
Merck & Co., Inc.
| New Jersey | 1-3305 | 22-1109110 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
||
| One Merck Drive, PO Box 100, Whitehouse Station, NJ | 08889-0100 | |
| (Address of principal executive offices) | (Zip Code) | |
Registrant’s telephone number, including area code
|
(908) 423-1000 | |
| N/A (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
Filed as part of this Current Report on Form 8-K are the consolidated balance sheets of
Merck & Co., Inc. and its subsidiaries at December 31, 2004 and December 31, 2003, and the related
consolidated statements of income, of retained earnings, of comprehensive income, and of cash flows
for each of the three years in the period ended December 31, 2004 (the “Financial Statements”), the
Notes to Consolidated Financial Statements, Management’s Report and the Report of Independent
Registered Public Accounting Firm, attached as Exhibit 99. Also filed with this Form 8-K are the
statement of Computation of Ratios of Earnings to Fixed Charges, attached as Exhibit 12 and the
Consent of Independent Registered Public Accounting Firm, attached as Exhibit 23.
Item 9.01. Financial Statements and Exhibits.
| (c) | Exhibits |
Exhibit 12
|
Computation of Ratios of Earnings to Fixed Charges | |
Exhibit 23
|
Consent of Independent Registered Public Accounting Firm | |
Exhibit 99
|
Financial Statements, Notes to Consolidated Financial Statements, Management’s Report and Report of Independent Registered Public Accounting Firm |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Merck & Co., Inc. | ||||
Date: February 28, 2005
|
By: | /s/ Debra A. Bollwage | ||
| DEBRA A. BOLLWAGE Senior Assistant Secretary |
||||
EXHIBIT INDEX
Exhibit |
||
Number
|
Description | |
Exhibit 12
|
Computation of Ratios of Earnings to Fixed Charges | |
Exhibit 23
|
Consent of Independent Registered Public Accounting Firm | |
Exhibit 99
|
Financial Statements, Notes to Consolidated Financial Statements, Management’s Report and Report of Independent Registered Public Accounting Firm |